Chaim Lebovits - 10 May 2024 Form 4/A Insider Report for BRAINSTORM CELL THERAPEUTICS INC. (BCLI)

Role
President & CEO
Signature
/s/ Chaim Lebovits
Issuer symbol
BCLI
Transactions as of
10 May 2024
Net transactions value
+$18,865
Form type
4/A
Filing time
31 Jul 2024, 16:07:56 UTC
Date Of Original Report
14 May 2024
Previous filing
07 May 2024
Next filing
23 May 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BCLI Common Stock Purchase $9,300 +20,000 +1.9% $0.4650 1,079,865 10 May 2024 Direct F1
transaction BCLI Common Stock Purchase $4,665 +10,000 +0.93% $0.4665 1,089,865 11 May 2024 Direct F1
transaction BCLI Common Stock Purchase $4,900 +10,000 +0.92% $0.4900 1,099,865 13 May 2024 Direct F1
holding BCLI Common Stock 2,000,847 10 May 2024 See footnote F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On May 14, 2024, the Reporting Person filed a Form 4 which inadvertently included incorrect transaction codes due to an administrative error. This amendment is being filed solely to reflect the correct transaction code 'P' instead of transaction code 'A'.
F2 Includes (i) 1,933,794 shares of Common Stock owned by ACCBT Corp. and (ii) 67,053 shares of Common Stock owned by ACC International Holdings Ltd. Reporting Person may be deemed the beneficial owner of these shares.